NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









DLOC Biosystems

DLOC Biosystems

Private
SandwichHealthcare & Life Scienceshttps://www.dlocbiosystems.com/

Last Round

Series A

Jan 20, 2026

Total Funding Raised

$2.6M

Company Overview

DLOC Biosystems is a biotechnology company that develops organ-on-chip technology and automated human-on-chip systems for pre-clinical drug testing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical Devices, Biotech Equipment, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

organ-on-chipdrug discoverypre-clinical testingbiomimetic modelscontract research organizationCROmicrofluidicsin-vitro testinglab-on-a-chipdrug development3D cell culturebiotech equipmentanimal testing alternativespredictive toxicologyAI-powered analysis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DLOC Biosystems Comparables

Compare DLOC Biosystems with similar companies based on industry and business-model similarity.

DLOC Biosystems comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AlveoliX AG
88%
MIMETAS
87%
Dynamic42
87%

DLOC Biosystems Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 20, 2026
AngelDec 16, 2025
Early FundingDec 16, 2025
AcceleratorOct 10, 2023
GrantNov 7, 2020

Key People

Founding team and executive leadership

Wadah Malaeb

Founder & CEO

Founding Team

Hadi Boustani

Chief Technology Officer

Executive Team

Mustafa Ammouri

Chief Technology Officer

Executive Team

DLOC Biosystems Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 10, 2023

    Completed an accelerator round of funding.

  • Nov 7, 2020

    $500K grant received from multiple organizations.

DLOC Biosystems Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

DLOC Biosystems Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DLOC Biosystems's valuation, stock price, and market status.

Firmographic Details

HeadquartersSandwich
Employee Range18
Year Founded2018
Last FundingJan 20, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.